Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation

Journal of Hepatology

Volumn 51, Issue 5, 2009, Pages 874-880

  Van Wagner, Lisa B ^a   Baker, Talia ^b   Ahya, Shubhada N ^a   Norvell, John P ^a   Wang, Edward ^a,b   Levitsky, Josh ^a,b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Hepatitis C virus; Interferon; Kidney transplantation; Liver transplantation; Recurrent disease; Simultaneous liver kidney transplantation

Indexed keywords

METHYLPREDNISOLONE; PEGINTERFERON; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG WITHDRAWAL; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FIBROSIS; LIVER GRAFT REJECTION; LIVER KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MORTALITY; PANCYTOPENIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT INFECTION; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ANTIVIRAL AGENTS; CASE-CONTROL STUDIES; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMANS; INTERFERON TYPE I, RECOMBINANT; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECURRENCE; RETROSPECTIVE STUDIES; RIBAVIRIN; TREATMENT OUTCOME;

EID: 70349733011     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2009.05.025     Document Type: Article

References (35)

1. Locke J.E., Warren D.S., Singer A.L., Segev D.L., Simpkins C.E., Maley W.R., et al. Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts. Transplantation 85 (2008) 935-942
2. Davis C.L., Feng S., Sung R., Wong F., Goodrich N.P., Melton L.B., et al. Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant 7 (2007) 1702-1709
3. Yoo H.Y., and Thuluvath P.J. Short-term post liver transplant survival after the introduction of MELD scores for organ allocation in the United States. Liver Int 25 (2005) 536-541
4. Gonwa T.A., McBride M.A., Anderson K., Mai M.L., Wadei H., and Ahsan N. Continued influence of preoperative renal function on outcome of orthotopic liver transplant (OLTX) in the US: where will MELD lead us?. Am J Transplant 6 (2006) 2651-2659
5. Campbell M.S., Kotlyar D.S., Brensinger C.M., Lewis J.D., Shetty K., Bloom R.D., et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 11 (2005) 1048-1055
6. Cohen A.J., Stegall M.D., Rosen C.B., Wiesner R.H., Leung N., Kremers W.K., et al. Chronic renal dysfunction late after liver transplantation. Liver Transpl 8 (2002) 916-921
7. Marik P.E., Wood K., and Starzl T.E. The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant 21 (2006) 478-482
8. Pawarode A., Fine D.M., and Thuluvath P.J. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transpl 9 (2003) 741-747
9. Thompson J.A., and Lake J.R. Review of hepatitis C in liver transplantation. Transplantation Updates 2 (2008) 3-12
10. Guitard J., Ribes D., Kamar N., Cointault O., Lavayssiere L., Esposito L., et al. Predictive factors for chronic renal failure one year after orthotopic liver transplantation. Ren Fail 28 (2006) 419-425
11. Ojo A.O., Held P.J., Port F.K., Wolfe R.A., Leichtman A.B., Young E.W., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 931-940
12. Yoo H., and Thuluvath P. The effect of insulin-dependent diabetes mellitus on outcome of liver transplantation. Transplantation 7 (2002) 1007-1012
13. Delgado-Borrego A., Casson D., Schoenfeld D., Somsouk M., Terelia A., Jordan S.H., et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 77 (2004) 703-710
14. Saliba F., Lakehal M., Pageaux G.-P., Roche B., Vanlemmens C., Duvoux C., et al. Risk factors for new-onset diabetes mellitus following liver transplantation and impact of hepatitis C infection: an observational multicenter study. Liver Transpl 13 (2007) 136-144
15. Thervet E., Pol S., Legendre C., Gagnadoux M., Cavalcanti R., and Kreis H. Low-dose recombinant leukocyte interferon-alpha treatment of hepatitis C viral infection in renal transplant recipients. A pilot study. Transplantation 58 (1994) 625-628
16. Magnone M., Holley J.L., Shapiro R., Scantelbury V., McCauley J., Jordan M., et al. Interferon-alpha-induced acute renal allograft rejection. Transplantation 59 (1995) 1068-1070
17. Rostaing L., Izopet J., Baron E., Duffaut M., Puel J., and Durand D. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients. Transplantation 59 (1995) 1426-1431
18. Rostaing L., Modesto A., Baron E., Cisterne J.M., Chabannier H., and Durand D. Acute renal failure in kidney transplant patients treated with interferon alpha 2b for chronic hepatitis C. Nephron 74 (1996) 512-516
19. Baid S., Tolkoff-Rubin N., Saidman S., Chung R., Williams W.W., Auchincloss H., et al. Acute humoral rejection in hepatitis C-infected renal transplant recipients receiving antiviral therapy. Am J Transplant 3 (2003) 74-78
20. Rostaing L. Treatment of hepatitis C virus infection after renal transplantation: new insights. Nephrol Dial Transplant 15 Suppl 8 (2000) S74-S76
21. Kamar N., Ribes D., Izopet J., and Rostaing L. Treatment of hepatitis C virus infection after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant. Transplantation 82 (2006) 853-856
22. Mukherjee S., and Ariyarantha K. Successful eradication of recurrent HCV with preservation of renal function in a liver-kidney transplant recipient with pegylated interferon and ribavirin. Transplantation 84 (2007) 1374-1375
23. Montalbano M., Pasulo L., Sonzogni A., Remuzzi G., Colledan M., and Strazzabosco M. Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobulinemia in a liver/kidney transplant recipient. J Clin Gastroenterol 41 (2007) 216-220
24. Schmitz V., Kiessling A., Bahra M., Puhl G., Kahl A., Berg T., et al. Peginterferon alfa-2b plus ribavirin for the treatment of hepatitis C recurrence following combined liver and kidney transplantation. Ann Transplant 12 (2007) 22-27
25. METAVIR cooperative group. Inter- and intra-observer variation in the assessment of liver biopsy in chronic hepatitis C. Hepatology 1994;20:15-20.
26. Port F.K., Bragg-Gresham J.L., Metzger R.A., Dykstra D.M., Gillespie B.W., Young E.W., et al. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 74 (2002) 1281-1286
27. Durlik M., Gaciong Z., Rowinska D., Rancewicz Z., Lewandowska D., Kozlowska B., et al. Long-term results of treatment of chronic hepatitis B, C and D with interferon-alpha in renal allograft recipients. Transpl Int 11 Suppl 1 (1998) S135-S139
28. Ruiz R., Kunitake H., Wilkinson A.H., Danovitch G.M., Farmer D.G., Ghobrial R.M., et al. Long-term analysis of combined liver and kidney transplantation at a single center. Arch Surg 141 (2006) 735-742
29. Fong T.L., Bunnapradist S., Jordan S.C., Selby R.R., and Cho Y.W. Analysis of the United Network for Organ Sharing database comparing renal allografts and patient survival in combined liver-kidney transplantation with the contralateral allografts in kidney alone or kidney-pancreas transplantation. Transplantation 76 (2003) 348-353
30. Calne R.Y., Davis D.R., Hadjiyannakis E., Sells R.A., White D., Herbertson B.M., et al. Immunosuppressive effects of soluble cell membrane fractions, donor blood and serum on renal allograft survival. Nature 227 (1970) 903-906
31. Rasmussen A., Davies H.F., Jamieson N.V., Evans D.B., and Calne R.Y. Combined transplantation of liver and kidney from the same donor protects the kidney from rejection and improves kidney graft survival. Transplantation 59 (1995) 919-921
32. Opelz G., Margreiter R., and Dohler B. Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too. Transplantation 74 (2002) 1390-1394
33. Audard V., Matignon M., Dahan K., Lang P., and Grimbert P. Renal transplantation from extended criteria cadaveric donors: problems and perspectives overview. Transpl Int 21 (2008) 11-17
34. Wadei H.M., Geiger X.J., Cortese C., Mai M.L., Kramer D.J., Rosser B.G., et al. Kidney allocation to liver transplant candidates with renal failure of undetermined etiology: role of percutaneous renal biopsy. Am J Transpl 8 (2008) 2618-2626
35. Eason J.D., Gonwa T.A., Davis C.L., Sung R.S., Gerber D., and Bloom R.D. Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK). Am J Transpl 8 (2008) 2243-2251